Review of the role of probiotics in gastrointestinal diseases in adults

Penner, 2005, Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases, Curr Opin Pharmacol, 5, 596, 10.1016/j.coph.2005.06.009 Sullivan, 2005, Probiotics and gastrointestinal diseases, J Intern Med, 257, 78, 10.1111/j.1365-2796.2004.01410.x Girardin, 2011, Indications for the use of probiotics in gastrointestinal diseases, Dig Dis, 29, 574, 10.1159/000332980 Sullivan, 2005, Probiotics and gastrointestinal diseases, J Intern Med, 257, 78, 10.1111/j.1365-2796.2004.01410.x Passariello, 2014, A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases, Curr Med Res Opin, 30, 1055, 10.1185/03007995.2014.898138 Islam, 2016, Clinical uses of probiotics, Medicine (Baltimore), 95, e2658, 10.1097/MD.0000000000002658 Marteau, 2006, Living drugs for gastrointestinal diseases: the case for probiotics, Dig Dis, 24, 137, 10.1159/000090317 Bergonzelli, 2005, Probiotics as a treatment strategy for gastrointestinal diseases?, Digestion, 72, 57, 10.1159/000087638 Wasilewski, 2015, Beneficial effects of probiotics, prebiotics, synbiotics, and psychobiotics in inflammatory bowel disease, Inflamm Bowel Dis, 21, 1674, 10.1097/MIB.0000000000000364 Issa, 2014, Probiotics for antibiotic-associated diarrhea: do we have a verdict?, World J Gastroenterol, 20, 17788, 10.3748/wjg.v20.i47.17788 Allen, 2015, The potential of probiotics to prevent Clostridium difficile infection, Infect Dis Clin N Am, 29, 135, 10.1016/j.idc.2014.11.002 Shojania, 2001, Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy, Eff Clin Pract, 4, 157 Allen, 2010, Probiotics for treating acute infectious diarrhoea, Cochrane Database Syst Rev, CD003048 Rijkers, 2010, Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research, J Nutr, 140, 671S, 10.3945/jn.109.113779 Preidis, 2011, Probiotics, enteric and diarrheal diseases, and global health, Gastroenterology, 140, 8, 10.1053/j.gastro.2010.11.010 Jafarnejad, 2016, Probiotics reduce the risk of antibiotic-associated diarrhea in adults (18–64 years) but not the elderly (>65 years): a meta-analysis, Nutr Clin Pract, 31, 502, 10.1177/0884533616639399 Hempel, 2012, Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis, JAMA, 307, 1959, 10.1001/jama.2012.3507 Szajewska, 2015, Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults, Aliment Pharmacol Ther, 42, 1149, 10.1111/apt.13404 Szajewska, 2015, Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea, Aliment Pharmacol Ther, 42, 793, 10.1111/apt.13344 Patro-Golab, 2015, Yogurt for treating antibiotic-associated diarrhea: systematic review and meta-analysis, Nutrition, 31, 796, 10.1016/j.nut.2014.11.013 Goldenberg, 2013, Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children, Cochrane Database Syst Rev, CD006095 Johnston, 2012, Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis, Ann Intern Med, 157, 878, 10.7326/0003-4819-157-12-201212180-00563 Lau, 2016, Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis, Int J Gen Med, 9, 27 Maziade, 2013, Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital, Curr Med Res Opin, 29, 1341, 10.1185/03007995.2013.833501 Allen, 2013, Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 382, 1249, 10.1016/S0140-6736(13)61218-0 McFarland, 2007, Meta-analysis of probiotics for the prevention of traveler's diarrhea, Travel Med Infect Dis, 5, 97, 10.1016/j.tmaid.2005.10.003 Takahashi, 2007, Probiotics in the prevention of traveler's diarrhea: meta-analysis, J Clin Gastroenterol, 41, 336, 10.1097/01.mcg.0000225546.34374.6d McLaughlin, 2008, Review article: restorative proctocolectomy, indications, management of complications and follow-up – a guide for gastroenterologists, Aliment Pharmacol Ther, 27, 895, 10.1111/j.1365-2036.2008.03643.x Turroni, 2010, Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach, World J Gastroenterol, 16, 30 Shen, 2014, Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials, Inflamm Bowel Dis, 20, 21, 10.1097/01.MIB.0000437495.30052.be Elahi, 2008, On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials, Dig Dis Sci, 53, 1278, 10.1007/s10620-007-0006-z Tomasz, 2014, Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective study, Biomed Res Int, 2014, 208064, 10.1155/2014/208064 Persborn, 2013, The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis, Aliment Pharmacol Ther, 38, 772, 10.1111/apt.12451 Holubar, 2010, Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis, Cochrane Database Syst Rev, CD001176 Ringel, 2009, Alterations in the intestinal microbiota and functional bowel symptoms, Gastrointest Endosc Clin N Am, 19, 141, 10.1016/j.giec.2008.12.004 Salonen, 2010, Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives, Microbiology, 156, 3205, 10.1099/mic.0.043257-0 Moayyedi, 2010, The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review, Gut, 59, 325, 10.1136/gut.2008.167270 Brenner, 2009, The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review, Am J Gastroenterol, 104, 1033, 10.1038/ajg.2009.25 Hoveyda, 2009, A systematic review and metaanalysis: probiotics in the treatment of irritable bowel syndrome, BMC Gastroenterol, 9, 15, 10.1186/1471-230X-9-15 McFarland, 2008, Meta-analysis of probiotics for the treatment of irritable bowel syndrome, World J Gastroenterol, 14, 2650, 10.3748/wjg.14.2650 Parkes, 2010, Treating irritable bowel syndrome with probiotics: the evidence, Proc Nutr Soc, 69, 187, 10.1017/S002966511000011X Ford, 2014, Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis, Am J Gastroenterol, 109, 1547, 10.1038/ajg.2014.202 Ringel, 2011, The rationale and clinical effectiveness of probiotics in irritable bowel syndrome, J Clin Gastroenterol, S145, 10.1097/MCG.0b013e31822d32d3 Lorenzo-Zúñiga, 2014, I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life, World J Gastroenterol, 20, 8709, 10.3748/wjg.v20.i26.8709 Yoon, 2014, Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial, J Gastroenterol Hepatol, 29, 52, 10.1111/jgh.12322 McKenzie, 2016, British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update), J Hum Nutr Diet Begtrup, 2013, Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial, Scand J Gastroenterol, 48, 1127, 10.3109/00365521.2013.825314 Whorwell, 2006, Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome, Am J Gastroenterol, 101, 1581, 10.1111/j.1572-0241.2006.00734.x O’Mahony, 2005, Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles, Gastroenterology, 128, 541, 10.1053/j.gastro.2004.11.050 Nobaek, 2000, Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome, Am J Gastroenterol, 95, 1231, 10.1111/j.1572-0241.2000.02015.x Saggioro, 2004, Probiotics in the treatment of irritable bowel syndrome, J Clin Gastroenterol, 38, S104, 10.1097/01.mcg.0000129271.98814.e2 Carroll, 2011, Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome, Am J Physiol Gastrointest Liver Physiol, 301, G799, 10.1152/ajpgi.00154.2011 Ortiz-Lucas, 2013, Effect of probiotic species on irritable bowel syndrome symptoms: a bring up to date meta-analysis, Rev Esp Enferm Dig, 105, 19, 10.4321/S1130-01082013000100005 Ortiz Lucas, 2014, Probiotics for specific treatment of pain in irritable bowel syndrome: a review, Rev Col Gastroenterol, 29, 146 Khalif, 2005, Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation, Dig Liver Dis, 37, 838, 10.1016/j.dld.2005.06.008 Quigley, 2007, Bacteria: a new player in gastrointestinal motility disorders–infections, bacterial overgrowth, and probiotics, Gastroenterol Clin N Am, 36, 735, 10.1016/j.gtc.2007.07.012 Waller, 2011, Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults, Scand J Gastroenterol, 46, 1057, 10.3109/00365521.2011.584895 Dimidi, 2014, The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials, Am J Clin Nutr, 100, 1075, 10.3945/ajcn.114.089151 Chmielewska, 2010, Systematic review of randomised controlled trials: probiotics for functional constipation, World J Gastroenterol, 16, 69 Gisbert, 2013, III Spanish Consensus Conference on Helicobacter pylori infection, Gastroenterol Hepatol, 36, 340, 10.1016/j.gastrohep.2013.01.011 Campillo, 2016, Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection, Med Clin (Barc) Gisbert, 2010, Sequential therapy for Helicobacter pylori eradication: a critical review, J Clin Gastroenterol, 44, 313, 10.1097/MCG.0b013e3181c8a1a3 Tong, 2007, Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy, Aliment Pharmacol Ther, 25, 155, 10.1111/j.1365-2036.2006.03179.x Dajani, 2013, Do probiotics improve eradication response to Helicobacter Pylori on standard triple or sequential therapy?, Saudi J Gastroenterol, 19, 113, 10.4103/1319-3767.111953 Wilhelm, 2011, Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori, Ann Pharmacother, 45, 960, 10.1345/aph.1Q104 Zhang, 2015, Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis, World J Gastroenterol, 21, 4345, 10.3748/wjg.v21.i14.4345 Ma, 2015, Probiotics in the treatment of peptic ulcer infected by Helicobacter pylori and its safety, Pak J Pharm Sci, 28, 1087 Zheng, 2013, Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: evidence from a meta-analysis, Rev Esp Enferm Dig, 105, 445, 10.4321/S1130-01082013000800002 Dore, 2015, Is there a role for probiotics in Helicobacter pylori therapy?, Gastroenterol Clin N Am, 44, 565, 10.1016/j.gtc.2015.05.005 Mukai, 2002, Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri, FEMS Immunol Med Microbiol, 32, 105, 10.1111/j.1574-695X.2002.tb00541.x Dore, 2016, Inclusion of Lactobacillus Reuteri in the treatment of Helicobacter pylori in sardinian patients: a case report series, Medicine (Baltimore), 95, e3411, 10.1097/MD.0000000000003411 Holz, 2015, Significant reduction in Helicobacter pylori load in humans with non-viable Lactobacillus reuteri DSM17648: a pilot study, Probiotics Antimicrob Proteins, 7, 91, 10.1007/s12602-014-9181-3 Szajewska, 2015, Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection, Aliment Pharmacol Ther, 41, 1237, 10.1111/apt.13214 Naidoo, 2011, Probiotics for maintenance of remission in ulcerative colitis, Cochrane Database Syst Rev, CD007443 Do, 2010, Probiotics for maintaining remission of ulcerative colitis in adults, Ann Pharmacother, 44, 565, 10.1345/aph.1M498 Zocco, 2006, Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis, Aliment Pharmacol Ther, 23, 1567, 10.1111/j.1365-2036.2006.02927.x Derikx, 2016, Probiotics and prebiotics in ulcerative colitis, Best Pract Res Clin Gastroenterol, 30, 55, 10.1016/j.bpg.2016.02.005 Chibbar, 2015, Probiotics in the management of ulcerative colitis, J Clin Gastroenterol, 49, S50, 10.1097/MCG.0000000000000368 Meijer, 2011, Probiotics in the treatment of human inflammatory bowel diseases: update 2011, J Clin Gastroenterol, S139, 10.1097/MCG.0b013e31822103f7 Floch, 2015, Recommendations for probiotic use—2015 update: proceedings and consensus opinion, J Clin Gastroenterol, 49, S69, 10.1097/MCG.0000000000000420 Kruis, 2004, Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine, Gut, 53, 1617, 10.1136/gut.2003.037747 Jonkers, 2012, Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients, Drugs, 72, 803, 10.2165/11632710-000000000-00000 Mardini, 2014, Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis, Inflamm Bowel Dis, 20, 1562, 10.1097/MIB.0000000000000084 Tursi, 2010, Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study, Am J Gastroenterol, 105, 2218, 10.1038/ajg.2010.218 Prantera, 2002, Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG, Gut, 51, 405, 10.1136/gut.51.3.405 Schultz, 2004, Lactobacillus GG in inducing and maintaining remission of Crohn's disease, BMC Gastroenterol, 4, 1, 10.1186/1471-230X-4-5 Marteau, 2006, Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial, Gut, 55, 842, 10.1136/gut.2005.076604 Malchow, 1997, Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?, J Clin Gastroenterol, 25, 653, 10.1097/00004836-199712000-00021 Guslandi, 2015, Role of probiotics in Crohn's disease and in pouchitis, J Clin Gastroenterol, 49, S46, 10.1097/MCG.0000000000000351 Butterworth, 2008, Probiotics for induction of remission in Crohn's disease, Cochrane Database Syst Rev, CD006634 Rolfe, 2006, Probiotics for maintenance of remission in Crohn's disease, Cochrane Database Syst Rev, CD004826 Guslandi, 2000, Saccharomyces boulardii in maintenance treatment of Crohn's disease, Dig Dis Sci, 45, 1462, 10.1023/A:1005588911207 Bourreille, 2013, Saccharomyces boulardii does not prevent relapse of Crohn's disease, Clin Gastroenterol Hepatol, 11, 982, 10.1016/j.cgh.2013.02.021 Lichtenstein, 2016, Probiotics and prebiotics in Crohn's disease therapies, Best Pract Res Clin Gastroenterol, 30, 81, 10.1016/j.bpg.2016.02.002